Heat shock proteins (HSPs) are a class of chaperone proteins that are up- regulated in response to elevated temperature and other environmental stresses such as ultraviolet light, nutrient deprivation, and oxygen deprivation. The heat shock protein 90 (HSP90) has significant roles in maintaining transformation properties of cancer cells and in maintaining survival and growth potential of cancer cells. The biological role of HSP90 is mediated by its ability to interact with client proteins such as EGFR, RAF-1, Her2, Bcr-Abl, and STK11/LKB1 (serine/thronine kinase 11/LKB1). Due to its impact on multiple major hallmarks of tumorigenesis and development, HSP90 has emerged as a promising target for cancer therapeutic development. Through experimentation and database mining, researchers at Emory identified molecular markers which are predictive of tumor sensitivity to Hsp90 inhibitors. This invention describes novel predictive molecular markers to determine the sensitivity of tumor cells to Hsp90 inhibitors. This technology will provide a new treatment regime for a wide range of devastating cancers.
This technology offers novel predictive molecular markers for identifying cancer patient populations with enhanced sensitivity to Heat shock protein (Hsp90) targeting therapies and a potential therapeutic target to enhance the therapeutic effect of chemotherapeutics and radiotherapeutics.
由于技术保密工作限制,技术信息无法完全展现,请通过邮箱或短信联系我们,获取更多技术资料。
ability
deprivation
cells
predictive
sensitivity
markers
lkb1
hsp90
proteins
tumor